JNJ
King 👑Johnson & Johnson • Healthcare
Current price
$267.08
Dividend yield
2.01%
Current snapshot
Current profile
Balanced
1Y DPS +3.9% · payout 62.1%
Growth record
62 years
Consecutive increases
vs. 5Y average yield
-0.71%
5Y average 2.71%
Valuation context
Overvalued
Most recent ex-date 2026-08-25
Yield context
Current yield is compared with 2.71% over 5 years and 2.65% over 10 years. These comparisons are research context only, not a recommendation.
The most recent ex-dividend date was 2026-08-25.
Quote snapshot (US/Eastern): Sep 9, 2026, 4:00 PM. Quotes are indicative and may be delayed. Not investment advice. Disclaimer & sources
Payout record
JNJ dividend history — annual dividend per share
Total regular dividends Johnson & Johnson paid per share in each completed calendar year, summed from actual payment dates.
Latest full year
$5.14
2025
Years with data
15
Within 2011–2025
Annual growth
+6.1%
Compound annual rate
Change over period
+128%
Per share, cumulative
| Year | Dividend per share | Relative size | vs. prior year |
|---|---|---|---|
| 2025 | $5.14 | +4.7% | |
| 2024 | $4.91 | +4.5% | |
| 2023 | $4.70 | +5.6% | |
| 2022 | $4.45 | +6.2% | |
| 2021 | $4.19 | +5.3% | |
| 2020 | $3.98 | +6.1% | |
| 2019 | $3.75 | +5.9% | |
| 2018 | $3.54 | +6.6% | |
| 2017 | $3.32 | +5.4% | |
| 2016 | $3.15 | +6.8% | |
| 2015 | $2.95 | +6.9% | |
| 2014 | $2.76 | +6.6% | |
| 2013 | $2.59 | +7.9% | |
| 2012 | $2.40 | +6.7% | |
| 2011 | $2.25 | — |
Regular dividends only — special or one-time distributions are excluded so year-over-year changes reflect the ordinary payout. The current year is omitted until it is complete, and a dash marks a year whose source payment records are incomplete. Figures are summed from payment history and may differ from company-reported declared amounts.
Sector comparison
JNJ among Healthcare peers
Dividend yield
2.01%
Median 1.28%
+0.73% vs. sector median · Current yield compared with peers
1Y dividend growth
+3.9%
Median +5.9%
-1.9% vs. sector median · Trailing-12-month comparison
Payout ratio
62.1%
Median 30.4%
+31.7% vs. sector median · Comparable trailing-EPS ratios only
This panel compares the current site snapshot with tracked peers in the same sector. It is research context, not an investment recommendation.
JNJ Dividend Calculator
Editorial research
JNJ Research & Spotlight
Analysis2026-07-06
The Cost of a Dividend Nobody Doubts
Johnson & Johnson has raised its dividend for 62 consecutive years — a record only a handful of companies on earth can match — while committing about 61% of earnings to the payout. The reward for all that reliability is a modest yield: 2.01%, below the 2.28% median of the Dividend Kings we track. A higher price on the same dividend leaves a smaller yield behind. Safety is not free. It shows up as a premium price and a slimmer income stream.
The dividend itself is not the story. J&J will pay it. The real question is what an investor hands over for a dividend nobody doubts.
A Yield Trading Below Its Own History
Here is the tell. J&J yields 2.01% today, but its five-year average is 2.72% and its ten-year average is 2.66%. The current figure sits 26% under its own five-year norm. On a business this stable, a below-average yield almost always means the same thing: the price has run ahead of the dividend. Our screen reads it the same way and tags J&J Overvalued.
| Yield reference | Level | vs current |
|---|---|---|
| Current trailing yield | 2.01% | — |
| 5-year average | 2.72% | −26% |
| 10-year average | 2.66% | −25% |
What 62 Years of Raises Buys
The payout is ordinary, and that is worth saying plainly. J&J distributes 60.9% of earnings, a shade above the 58.4% median for a Dividend King. What is not ordinary is the streak: 62 straight years of increases. The coverage is unremarkable; the record is not. There is room to keep raising, and six decades of history saying the company will.
| Metric | J&J (JNJ) | King median |
|---|---|---|
| Dividend yield | 2.01% | 2.28% |
| Payout ratio | 60.9% | 58.4% |
| Consecutive raise years | 62 | 54 |
Look at the payout line. J&J spends about 61 cents of every earnings dollar on its dividend, and the median King spends about 58. On coverage alone, this is a thoroughly average member of the group — which is a useful corrective to the assumption that a famous streak implies an exceptional cushion. The Payout Ratio works through why coverage and record are separate questions.
Where the Streak Actually Earns Its Keep
If the coverage is average, what is J&J paying for? Duration. Sixty-two consecutive raises means the dividend was defended through the 1970s inflation, the 1987 crash, the dot-com bust, 2008, and a pandemic — and the 39 cents of every dollar the company retains has been enough to fund research and acquisitions the entire time. A 61% payout is not a fortress. It is a level that has proven sustainable across six decades at this particular business, which is a narrower but better-evidenced claim.
For total return, that distinction matters more than the headline 2.01%. J&J is not the Dividend King with the most headroom — Cincinnati Financial at 17.1% and Dover at 25.2% are far better covered. It is the one with among the longest unbroken records at a payout it has clearly been able to carry. Buyers are paying for the track record, not for spare capacity.
The Trade in One Line
So the read on J&J is not about danger. It is about price. The coverage is average for its tier, the payout has been carried at this level for decades, and the streak runs 62 years deep. The catch is that the market knows all of it and has pushed the yield down to 2.01% to match. Owning J&J here means paying up for certainty, not reaching for income. Whether that is a good deal rests less on the dividend and more on the entry price.
The dividend record and latest figures are in the company's filings on SEC EDGAR. How we group stocks by history tier and assign a current dividend profile is documented on our methodology page.
Disclaimer: This is informational only and not financial advice. Figures reflect the site snapshot dated 2026-08-13 and move with the market. Investing carries risk of loss, including loss of principal.
Peer reference
Similar Healthcare dividend stocks
Fund exposure
Top dividend ETFs holding JNJ
Among the dividend ETFs featured on this site, these reported the largest portfolio weight in this stock (Yahoo Finance top holdings; figures may lag or change).
Funds shown
5
Strategy types
2
Highest shown
3.14%
| ETF & fund profile | Portfolio weight |
|---|---|
| DGROiShares Core Dividend Growth Quality & growth~430 holdings | 3.14% |
| VIGVanguard Dividend Appreciation Quality & growth~338 holdings | 2.66% |
| VYMVanguard High Dividend Yield High yield~550 holdings | 2.51% |
| DLNWisdomTree US LargeCap Dividend High yield~300 holdings | 2.05% |
| DTDWisdomTree US Total Dividend High yield~900 holdings | 1.82% |
Shows the highest observed weights among dividend ETFs tracked on this site. Strategy labels and holdings counts are fund-level context; weights can change between snapshots.